华恒生物
(688639)
| 流通市值：186.15亿 | | | 总市值：186.56亿 |
| 流通股本：1.57亿 | | | 总股本：1.58亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 370,916,208.82 | 352,984,098.78 | 181,608,810.44 | 234,069,357.17 |
| 应收票据及应收账款 | 305,144,998.32 | 304,166,933.11 | 240,613,218.75 | 252,163,086.96 |
| 其中：应收票据 | 47,235,903.15 | 58,418,991.08 | 41,479,504.08 | 58,741,870.51 |
| 应收账款 | 257,909,095.17 | 245,747,942.03 | 199,133,714.67 | 193,421,216.45 |
| 应收款项融资 | 12,060,205.86 | 14,261,767.71 | 7,015,758.75 | 12,289,851.75 |
| 预付款项 | 52,127,044.04 | 29,223,417.35 | 52,550,146.02 | 24,272,592.15 |
| 其他应收款合计 | 17,024,844.28 | 10,465,105.69 | 8,955,607.17 | 7,495,724.26 |
| 其中:应收利息 | - | - | 8,684.73 | 13,768.28 |
| 存货 | 323,961,981.21 | 226,464,157.69 | 168,453,883.15 | 152,539,434.15 |
| 其他流动资产 | 127,078,861.64 | 112,480,925.69 | 73,737,397.25 | 45,815,112.68 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,208,314,144.17 | 1,050,046,406.02 | 752,938,520.16 | 758,682,145.42 |
| 非流动资产: | | | | |
| 其他非流动金融资产 | 118,500,033.33 | 112,400,033.33 | 89,218,200 | 62,400,000 |
| 固定资产 | 1,178,043,248.21 | 1,091,691,993.45 | 952,010,169.42 | 857,628,930.59 |
| 在建工程 | 1,678,588,538.34 | 1,528,529,944.18 | 631,918,614.46 | 398,216,868.97 |
| 无形资产 | 85,503,156.22 | 86,275,591.03 | 72,141,503.53 | 72,757,972.84 |
| 递延所得税资产 | 52,372,462.03 | 49,394,898.42 | 49,403,169.63 | 46,171,541.41 |
| 其他非流动资产 | 65,900,475.72 | 51,899,226.87 | 261,857,908.54 | 175,299,440.35 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 3,178,907,913.85 | 2,920,191,687.28 | 2,056,549,565.58 | 1,612,474,754.16 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 4,387,222,058.02 | 3,970,238,093.3 | 2,809,488,085.74 | 2,371,156,899.58 |
| 流动负债: | | | | |
| 短期借款 | 1,177,117,518.26 | 915,121,195.63 | 490,885,200.56 | 306,568,199.36 |
| 应付票据及应付账款 | 614,453,322.22 | 589,006,238.71 | 211,963,221.58 | 212,831,428.16 |
| 应付账款 | 614,453,322.22 | 589,006,238.71 | 211,963,221.58 | 212,831,428.16 |
| 合同负债 | 22,009,175.52 | 12,767,817.17 | 18,865,817.65 | 18,960,354.31 |
| 应付职工薪酬 | 16,023,213.11 | 31,071,567.28 | 21,791,323.29 | 19,091,071.48 |
| 应交税费 | 20,482,061.62 | 31,640,091.06 | 12,961,822.7 | 13,847,884.37 |
| 其他应付款合计 | 29,961,275.62 | 28,393,143.62 | 32,691,957.2 | 36,570,967.29 |
| 一年内到期的非流动负债 | 35,910,696.59 | 26,598,872.89 | 4,429,222.91 | - |
| 其他流动负债 | 26,881,852.58 | 41,879,676.1 | 1,188,085.89 | 1,104,723.37 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 1,942,839,115.52 | 1,676,478,602.46 | 794,776,651.78 | 608,974,628.34 |
| 非流动负债: | | | | |
| 长期借款 | 375,963,095.73 | 304,933,359.33 | 136,724,357.43 | - |
| 递延收益 | 90,076,426.74 | 91,526,814.42 | 97,585,402.1 | 99,267,989.78 |
| 递延所得税负债 | 76,574,641.92 | 71,638,541.91 | 79,019,780.02 | 70,029,772.08 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 542,614,164.39 | 468,098,715.66 | 313,329,539.55 | 169,297,761.86 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 2,485,453,279.91 | 2,144,577,318.12 | 1,108,106,191.33 | 778,272,390.2 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 157,540,180 | 157,540,180 | 157,540,180 | 157,540,180 |
| 资本公积 | 605,650,777.77 | 603,464,352.77 | 598,203,127.77 | 592,941,902.77 |
| 减:库存股 | 57,212,725.12 | 45,242,637.58 | 37,137,588.88 | 12,000,000 |
| 其他综合收益 | 744,681.34 | 721,619.52 | 799,585.8 | 706,274.61 |
| 盈余公积 | 55,632,195.85 | 55,632,195.85 | 37,718,323.54 | 37,718,323.54 |
| 未分配利润 | 1,141,429,576.37 | 1,054,855,465.25 | 943,657,066.88 | 814,944,515.27 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,903,784,686.21 | 1,826,971,175.81 | 1,700,780,695.11 | 1,591,851,196.19 |
| 少数股东权益 | -2,015,908.1 | -1,310,400.63 | 601,199.3 | 1,033,313.19 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,901,768,778.11 | 1,825,660,775.18 | 1,701,381,894.41 | 1,592,884,509.38 |
| 负债和股东权益合计 | 4,387,222,058.02 | 3,970,238,093.3 | 2,809,488,085.74 | 2,371,156,899.58 |
| 公告日期 | 2024-04-22 | 2024-04-22 | 2023-10-26 | 2023-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |